Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Bar, J.; ; | Hod, M.; | Merlob, P.; ;
Affiliations: The Beilinson Teratology Information Service, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel | Department of Neonatology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel | Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Campus, Petah Tiqva, Israel | Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
Note: [] Corresponding author. Address: Jacob Bar, M.D., Department of Obstetrics and Gynecology, Rabin Medical Center, Beilinson Campus, 49 100 Petah Tiqva, Israel.
Abstract: Angiotensin Converting Enzyme Inhibitors (ACE-I) have been very effective in treating hypertension. Adverse conditions in the fetus with the use of ACE-I, such as oligohydramnios, intra-uterine growth restriction (IUGR), hypocalvaria, persistent ductus arteriosus with fetal and neonatal death have been rerported. Though the pathophysiology was thought to be a problem with renal hypoperfusion in the fetus, it remained unclear whether the first trimester exposure to these drugs produced a similar pattern. We participated in a collaborative trial initiated by the Organization of Teratology Information Services (OTIS) in the United States to examine whether first trimester exposure to ACE-I was of concern. Eight women from our High Risk Pregnancy Unit who delivered in our hospital were enrolled in the trial. All were treated with either Enalapril or Captopril in the first trimester due to various reasons, mainly chronic hypertension and diabetic nephropathy. No major malformations were detected in the nine newborns studied (one pair of twins). Two cases of IUGR were diagnosed, one of them ended in an intra-uterine death, but this was attributed to maternal severe disease and probably not to drug effect. We are definitely not suggesting that women should stay on ACE-I until the second trimester, but it seems that renal blood flow and its associated problems with glomerular filtration are not affected in the first trimester.
Keywords: Drugs in pregnancy, ACE inhibitors, teratogenesis
DOI: 10.3233/JRS-1997-10102
Journal: International Journal of Risk and Safety in Medicine, vol. 10, no. 1, pp. 23-26, 1997
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
sales@iospress.com
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
info@iospress.nl
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office info@iospress.nl
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
china@iospress.cn
For editorial issues, like the status of your submitted paper or proposals, write to editorial@iospress.nl
如果您在出版方面需要帮助或有任何建, 件至: editorial@iospress.nl